BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16550510)

  • 1. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients.
    Falagas ME; Vardakas KZ
    Am J Hematol; 2006 Apr; 81(4):299-300. PubMed ID: 16550510
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trials of amphotericin B lipid complex.
    Boyle JA
    Clin Infect Dis; 2000 Oct; 31(4):1117-8. PubMed ID: 11049803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
    López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
    Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in antifungal prophylaxis strategies in lung transplantation.
    Husain S; Zaldonis D; Kusne S; Kwak EJ; Paterson DL; McCurry KR
    Transpl Infect Dis; 2006 Dec; 8(4):213-8. PubMed ID: 17116134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal amphotericin B for fever and neutropenia.
    Prentice HG; Kibbler CC
    N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal amphotericin B for fever and neutropenia.
    Fischer T; Heussel G; Huber C
    N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
    [No Abstract]   [Full Text] [Related]  

  • 8. Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
    Dekker AW; Verdonck LF; Rozenberg-Arska M
    Bone Marrow Transplant; 1994 Jul; 14(1):89-93. PubMed ID: 7951125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compassionate use protocol initiated for AmBisome.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B for fever and neutropenia.
    Winston DJ; Schiller GJ; Territo MC
    N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
    [No Abstract]   [Full Text] [Related]  

  • 11. Liposomal amphotericin B for fever and neutropenia.
    Rakita R
    N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Faucher C; Fürst S; Duran S; Berger P; Vey N; Stoppa AM; Bouabdallah R; Gastaut JA; Viens P; Blaise D; Mohty M
    Bone Marrow Transplant; 2007 Mar; 39(5):301-6. PubMed ID: 17262059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin.
    Trigg ME; Morgan D; Burns TL; Kook H; Rumelhart SL; Holida MD; Giller RH
    Bone Marrow Transplant; 1997 Jan; 19(1):43-7. PubMed ID: 9012930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B trial marred by conclusions.
    Wolf J; Buttery J; Daley AJ; Hanieh S; Shann F; Starr M; Curtis N
    Clin Infect Dis; 2007 Sep; 45(5):667-8; author reply 668-9. PubMed ID: 17683011
    [No Abstract]   [Full Text] [Related]  

  • 18. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
    Tollemar J; Höckerstedt K; Ericzon BG; Sundberg B; Ringdén O
    Transplant Proc; 1994 Jun; 26(3):1833. PubMed ID: 8030161
    [No Abstract]   [Full Text] [Related]  

  • 19. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
    Perfect JR; Dodds Ashley E; Drew R
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elution and mechanical properties of antifungal bone cement.
    Goss B; Lutton C; Weinrauch P; Jabur M; Gillett G; Crawford R
    J Arthroplasty; 2007 Sep; 22(6):902-8. PubMed ID: 17826283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.